Lung Transplants are indicated in individuals with end stage respiratory disease without co-morbidity
COPD is the commonest cause for a lung transplant in the UK (40%)
Post transplant regime includes immunosuppression- tacrolimus, MMF, steroids
Mean survival is 6 years, usually decline is through lung failure from chronic rejection (bronchiolitis obliterans) and subsequent infection
On average 150 lung transplants are performed each year, most commonly for COPD (40%)
Lung Transplant comes with substantial risks and are offered in those with end stage respiratory disease without frailty
Presentations
Progression of severe respiratory disease
Post transplant rejection:
Acute rejection
Chronic failure (Bronchiolitis Obliterans)
Examination
Other scars: tracheostomy, portacath/ Hickmann/ PICC
Examination may be normal +- finger clubbing
Signs of medication:
Fine tremor (tacrolimus), gum hypertrophy (cyclosporin- renal failure),
Diabetes - moon face, libra (pred),
Investigations
Post transplant acute presentation
Tacrolimus level
Pulmonary Function Tests
CXR +- CTPA or CT-T
Consider ddimer/ CTPA
Diagnoses:
COPD, ILD, CF/ bronchiectasis, Pulmonary HTN
Commonest- COPD 40% improves QoL > quantity, BODE index > 7yrs
Finger clubbing: CF/ bronchiectasis, ILD
Indications
Severe lung disease: > 50% risk of death in 2yrs without transplant
Functional reserve
> 80% Survive 90 days post transplant
> 80% of 5yr post transplant survival (with functioning transplant)
Contraindications
Absolute
Malignancy within 5 yrs
Organ vital failure- liver, renal, lung, brain, cardiac (unless
Severe infection- e.g. mycobacterium abscessus, burkhodelia
Frailty, BMI > 30, smoking/ recreational drugs
Compliance issues- psychosocial issues,
Relative: age > 65 yrs
Complications
Acute rejection, opportunistic infections
Chronic rejection: Bronchiolitis obliterans- terminal event
Infections
Malignancy: post transplant lymphoproliferative disease, skin
Median survival 6 yrs
MDT
Transplant centre: early referral, contact during admission
Lifestyle
Smoking cessation
Medical
Anti-rejection: tacrolimus, MMF, prednisolone
Prophylaxis: antibiotic, cotrimoxazole (PJP)
Surgical
Examination:
Postero-lateral thorocotomy scar
Examine other lung ?COPD/ ILD
Indications: ILD, COPD,
Examination
Clampshell anterior scar
Normal expansion, percussion, auscultation if working
Indications:
Classically suprarutive disease- CF/ bronchiectasis, generalised bronchiectasis
Also ILD with pulmonary HTN
Scar: midline sternotomy + lateral Thoracotomy
Indications
Lung disease (ILD/ Bronchiectasis/ COPD) with core pulmonale
Congenital heart & lung disease: Eisenmenger Syndrome
Systemic diseases such as Sarcoidosis
Written in 2025